Venomyx Therapeutics
Get Full AccessDescription
- Venomyx is bringing antivenom into the 21st century with the world's first toxin-specific snake antivenom. Our solution will make antivenom treatment safe, effective, and affordable for the millions of snakebite victims per year around the world. We are operating out of the IndieBio accelerator in San Francisco, CA. We are currently developing and conducting preclinical studies on our therapeutic candidates.
-
Headquarters:11011 North Torrey Pines Road Suite 135, La Jolla, California, United States
More -
Phone Number:
-
Website: https://www.venomyx.com
-
Employees:3
-
Revenue:$1 - 10M
-
Legal Name:Venomyx Therapeutics
-
Venomyx Therapeutics's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
View Employees
Frequently Asked Questions regarding Venomyx Therapeutics
-
Where are Venomyx Therapeutics's Headquarters?
Venomyx Therapeutics's Headquarters are in 11011 North Torrey Pines Road Suite 135,La Jolla,California,United States
-
What is Venomyx Therapeutics's official website?
Venomyx Therapeutics's official website is https://www.venomyx.com
-
What is Venomyx Therapeutics's Revenue?
Venomyx Therapeutics's revenue is $1 - 10M
-
What is Venomyx Therapeutics's NAICS code?
Venomyx Therapeutics's NAICS code is 541713
-
How many employees are working in Venomyx Therapeutics
Venomyx Therapeutics has 3 employees
-
What is Venomyx Therapeutics's Industry?
Venomyx Therapeutics is in the industry of Biotechnology
-
Who is Venomyx Therapeutics's CEO?
Venomyx Therapeutics's CEO is Dan Dempsey